US4298500A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Mixed phase chromatographic compositions
Assignee: Varian Medical Systems Inc
•
Filing: 1980-05-05
•
Granted: 1981-11-03
•
Expires: 2000-05-05
Abstract
Abstract The mixed phase packing material of this invention, enables rapid separation of multi-sited biopolymers. This separation is achieved by "tailoring" the distance between organo-silyl groups covalently bonded to the rigid support at the Angstrom distance needed for reversible separation of the biopolymers of interest and "capping" other sterically available active sites on the support with a relatively inert compound.
Inventors
- 👤 Seth R. Abbott
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-25 16:25
CPC Classifications
B; B01; B01J; B01J20/00; B01J20/281; B01J20/286; B01J20/287; B01J20/28; B01J20/28002; B01J20/28004; B01J20/28054; B01J20/28078; B01J20/30; B01J20/3092; B01J20/32; B01J20/3202; B01J20/3204; B01J20/3214; B01J20/3217; B01J20/3225; B01J20/3227; B01J20/3231; B01J20/3242; B01J20/3244; B01J20/3246; B01J20/3257; B01J20/3259; B01J20/3263; B01J20/3285; B01J39/00; B01J39/26; B01J41/00; B01J41/20; C; C12; C12N; C12N15/00; C12N15/09; C12N15/10; C12N15/1003; C12N15/1006; C12N15/101; B01J2220/00; B01J2220/50; B01J2220/54; B01J2220/58
Claims Analysis
Total Claims: 40
Claim 1
Independent Claim
83 words
A mixed phase composition comprising a porous particle suitable for use in chromatography having a first residue covalently bonded, to less than the maximum number of sterically available support matrix active sites, said first residue being capable of separating multiple-sorbable-sited compounds, said particle also having a second residue covalently bonded to other of the sterically available support matrix active sites, said second residue being inert or substantially inert to said compounds; said first and second residues being directly attached to said active sites.
Claim 2
Dependent Claim
83 words
A mixed phase composition comprising a porous particle suitable for use in chromatography having a first residue covalently bonded, to less than the maximum number of sterically available support matrix active sites, said first residue being capable of separating multiple-sorbable-sited compounds, said particle also having a second residue covalently bonded to other of the sterically available support matrix active sites, said second residue being inert or substantially inert to said compounds; said first and second residues being directly attached to said active sites.
Claim 3
Dependent Claim
13 words
The mixed phase composition of claim 1 wherein said porous particle is silica.
Claim 4
Dependent Claim
18 words
The mixed phase composition of claim 2 wherein said silica is a high performance liquid chromatography grade silica.
Claim 5
Dependent Claim
31 words
The mixed phase composition of claim 3 wherein said silica has a particle size of about 5 to about 20 microns and a pore size of about 100 to 4000 Angstroms.
Claim 6
Dependent Claim
48 words
The mixed phase composition of claim 1 or 2 wherein said first residue is formed from an organosilane group-containing reagent, said reagent being a weak anion exchange reagent, a strong anion exchange reagent, a weak cation exchange reagent, a strong cation exchange reagent, or a reverse phase reagent.
Claim 7
Dependent Claim
19 words
The mixed phase composition of claim 5 wherein said first residue is formed from a weak anion exchange reagent.
Claim 8
Dependent Claim
48 words
The mixed phase composition of claim 6 wherein said weak anion exchange reagent has the general formula: ##STR6## wherein n is an integer ranging from 2-5; R is methyl or ethyl; and X and Y are methyl or ethyl, with X and Y being the same or different.
Claim 9
Dependent Claim
17 words
The mixed phase composition of claim 7 wherein said weak anion exchange reagent is N, N- diethylaminopropyltrimethoxysilane.
Claim 10
Dependent Claim
21 words
The mixed phase composition of claim 1 wherein said first residue is bonded to less than 25% of said active sites.
Claim 11
Dependent Claim
31 words
The mixed phase composition of claim 1 or 2 wherein said second residue is formed from an organosilane group-containing reagent, said reagent being a diol, a diol precursor or an amide.
Claim 12
Dependent Claim
35 words
The mixed phase composition of claim 10 wherein said second residue is formed from a diol having the general formula: ##STR7## wherein n is an integer ranging from 2-5; and R is methyl or ethyl.
Claim 13
Dependent Claim
17 words
The mixed phase composition of claim 10 wherein said second residue is formed from a diol precursor.
Claim 14
Dependent Claim
36 words
The mixed phase composition of claim 10 wherein said second residue is formed from a diol precursor having the general formula: ##STR8## wherein n is an integer ranging from 2-5; and R is methyl or ethyl.
Claim 15
Dependent Claim
13 words
The mixed phase composition of claim 13 wherein said diol precursor is γ-glycidoxypropyltrimethoxysilane.
Claim 16
Dependent Claim
16 words
The mixed phase composition of claim 10 wherein said second residue is formed from an amide.
Claim 17
Dependent Claim
34 words
The mixed phase composition of claim 15 wherein said amide has the general formula: ##STR9## wherein n is an integer ranging from 2-5; R is methyl or ethyl, and R' is methyl or ethyl.
Claim 18
Dependent Claim
12 words
The mixed phase composition of claim 16 wherein said amide is N-(3-triethoxysilylpropyl)acetamide.
Claim 19
Dependent Claim
228 words
A process for the manufacture of a mixed phase composition comprising a porous particle suitable for use in chromatography having a first residue covalently bonded, to less than the maximum number of sterically available support matrix active sites, said first residue being capable of separating multiple-sorbable-sited compounds, said particle also having a second residue covalently bonded to other of the sterically available support matrix active sites, said second residue being inert or substantially inert to said compounds; said first and second residues being directly attached to said active sites; said process comprising the steps of: (a) degassing said particle, (b) reacting the reagent from which said first residue is formed with an aqueous slurry of said degassed particle at a time and temperature sufficient to covalently bond said first residue to said active sites; said particle being present in a stoichiometric excess, said excess being that of said active sites of said particle to said reagent, whereby less than the maximum number of sterically available porous particle active sites are bonded by said first residue; (c) reacting the product of the previous step with the reagent from which said second residue is formed, in a degassed aqueous slurry at a time and temperature sufficient to covalently bond said second residue directly to other of the sterically available porous particle active sites; and (d) recovering said mixed phase composition.
Claim 20
Dependent Claim
228 words
A process for the manufacture of a mixed phase composition comprising a porous particle suitable for use in chromatography having a first residue covalently bonded, to less than the maximum number of sterically available support matrix active sites, said first residue being capable of separating multiple-sorbable-sited compounds, said particle also having a second residue covalently bonded to other of the sterically available support matrix active sites, said second residue being inert or substantially inert to said compounds; said first and second residues being directly attached to said active sites; said process comprising the steps of: (a) degassing said particle, (b) reacting the reagent from which said first residue is formed with an aqueous slurry of said degassed particle at a time and temperature sufficient to covalently bond said first residue to said active sites; said particle being present in a stoichiometric excess, said excess being that of said active sites of said particle to said reagent, whereby less than the maximum number of sterically available porous particle active sites are bonded by said first residue; (c) reacting the product of the previous step with the reagent from which said second residue is formed, in a degassed aqueous slurry at a time and temperature sufficient to covalently bond said second residue directly to other of the sterically available porous particle active sites; and (d) recovering said mixed phase composition.
Claim 21
Dependent Claim
17 words
The process according to claim 18 wherein said particle is a high performance liquid chromatography grade silica.
Claim 22
Dependent Claim
34 words
The process according to claim 18 wherein the reaction of step (b) is carried out at about 20° C. to 50° C. for a period of from about 15 minutes to about 24 hours.
Claim 23
Dependent Claim
30 words
The process according to claim 18 wherein the reaction of step (c) is carried out at reflux temperature for a period of from about 1 hour to about 4 hours.
Claim 24
Dependent Claim
31 words
The process according to claim 19 wherein said silica has a particle size of from about 5 to about 20 microns and a pore size of about 100 to 4000 Angstroms.
Claim 25
Dependent Claim
47 words
The process according to claim 18 or 19 wherein said first residue is formed from an organosilane group-containing reagent, said reagent being a weak anion exchange reagent, a strong anion exchange reagent, a weak cation exchange reagent, a strong cation exchange reagent, or a reverse phase reagent.
Claim 26
Dependent Claim
18 words
The process according to claim 23 wherein said first residue is formed from a weak anion exchange reagent.
Claim 27
Dependent Claim
47 words
The process according to claim 24 wherein said weak anion exchange reagent has the general formula: ##STR10## wherein n is an integer ranging from 2-5; R is methyl or ethyl; and X and Y are methyl or ethyl, with X and Y being the same or different.
Claim 28
Dependent Claim
14 words
The process according to claim 25 wherein said weak anion exchange reagent is N,N-diethylaminopropyltrimethoxysilane.
Claim 29
Dependent Claim
55 words
The process according to claim 18 or 19 wherein said second residue is formed from an organosilane group-containing reagent, said reagent being a diol, a diol precursor, or an amide; provided that if the residue is formed from the diol precursor, the process further comprises hyrolyzing the product of step (c) to form a diol.
Claim 30
Dependent Claim
34 words
The process according to claim 27 wherein said second residue is formed from a diol having the general formula: ##STR11## wherein n is an integer ranging from 2-5; and R is methyl or ethyl.
Claim 31
Dependent Claim
16 words
The process according to claim 27 wherein said second residue is formed from a diol precursor.
Claim 32
Dependent Claim
35 words
The process according to claim 29 wherein said second residue is formed from a diol precursor having the general formula: ##STR12## wherein n is an integer ranging from 2-5; and R is methyl or ethyl.
Claim 33
Dependent Claim
12 words
The process according to claim 30 wherein said diol precursor is γ-glycidoxypropyltrimethoxysilane.
Claim 34
Dependent Claim
15 words
The process according to claim 27 wherein said second residue is formed from an amide.
Claim 35
Dependent Claim
33 words
The process according to claim 32 wherein said amide has the general formula: ##STR13## wherein n is an integer ranging from 2-5; R is methyl or ethyl, and R' is methyl or ethyl.
Claim 36
Dependent Claim
12 words
The process according to claim 33 wherein said amide is N-(3-triethoxysilylpropyl) acetamide.
Claim 37
Dependent Claim
34 words
The process according to claim 18 wherein the sterically available active sites of the particle range from about 10-50:1, on a molar basis, relative to the reagent from which the first residue is formed.
Claim 38
Dependent Claim
13 words
The process according to claim 18 wherein said multiple-sorbable-sited compound is a biopolymer.
Claim 39
Dependent Claim
13 words
The process according to claim 36 wherein said biopolymer is a nucleic acid.
Claim 40
Dependent Claim
12 words
The process according to claim 37 wherein said nucleic acid is transfer-RNA.
References Cited (Backward Citations)
US3505785A
Cited
US3983299A
Cited
US4029583A
Cited
US4180383A
Cited
US4108603A
Cited
US4111838A
Cited
US4199330A
Cited
US4242227A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1984-11-02 | 1985-05-04 | 1985-11-03 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1988-11-02 | 1989-05-04 | 1989-11-03 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1992-11-02 | 1993-05-04 | 1993-11-03 | $7700.00 | Window Closed / Lapsed |